首页> 外国专利> compound, pharmaceutical composition, methods for eliciting an agonist effect, and an antagonist effect of a gip receptor, for treating conditions or diseases, for treating disorders, for treating or preventing secondary causes of diabetes, and for stimulating insulin secretion in an individual , and, use of a compound

compound, pharmaceutical composition, methods for eliciting an agonist effect, and an antagonist effect of a gip receptor, for treating conditions or diseases, for treating disorders, for treating or preventing secondary causes of diabetes, and for stimulating insulin secretion in an individual , and, use of a compound

机译:化合物,药物组合物,引起gip受体激动剂作用和拮抗作用的方法,用于治疗病症或疾病,用于治疗疾病,用于治疗或预防糖尿病的继发性原因以及用于刺激个体的胰岛素分泌的方法,以及,使用化合物

摘要

There is provided a novel series of analogues of glucose-dependent insulinotropic polypeptide, pharmaceutical compositions containing said compounds, and the use of said compounds as GIP-receptor agonists or antagonists for treatment of GIP-receptor mediated conditions, such as non-insulin dependent diabetes mellitus and obesity.
机译:提供了一系列新的葡萄糖依赖性促胰岛素多肽类似物,包含所述化合物的药物组合物,以及所述化合物作为GIP受体激动剂或拮抗剂用于治疗GIP受体介导的疾病例如非胰岛素依赖性糖尿病的用途。和肥胖。

著录项

  • 公开/公告号BRPI0916890A2

    专利类型

  • 公开/公告日2019-09-24

    原文格式PDF

  • 申请/专利权人 IPSEN PHARMA S.A.S.;

    申请/专利号BR2009PI16890

  • 发明设计人 ZHENG XIN DONG;

    申请日2009-08-07

  • 分类号C07K14/62;C07K14/46;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号